Zhang H - Search Results

1

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker.

Zhang J, Fu M, Zhang M, Zhang J, Du Z, Zhang H, Hua W, Mao Y. Zhang J, et al. Among authors: zhang m, zhang h. Front Oncol. 2021 Jun 10;11:665360. doi: 10.3389/fonc.2021.665360. eCollection 2021. Front Oncol. 2021. PMID: 34178649 Free PMC article.

2

Hypoxia in Breast Cancer-Scientific Translation to Therapeutic and Diagnostic Clinical Applications.

Zhang Y, Zhang H, Wang M, Schmid T, Xin Z, Kozhuharova L, Yu WK, Huang Y, Cai F, Biskup E. Zhang Y, et al. Among authors: zhang h. Front Oncol. 2021 Mar 11;11:652266. doi: 10.3389/fonc.2021.652266. eCollection 2021. Front Oncol. 2021. PMID: 33777815 Free PMC article. Review.

3

Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer.

Zhang H, Lin X, Huang Y, Wang M, Cen C, Tang S, Dique MR, Cai L, Luis MA, Smollar J, Wan Y, Cai F. Zhang H, et al. Front Oncol. 2021 Jun 2;11:652253. doi: 10.3389/fonc.2021.652253. eCollection 2021. Front Oncol. 2021. PMID: 34150621 Free PMC article. Review.

4

Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.

Xu S, Li X, Zhang H, Zu L, Yang L, Shi T, Zhu S, Lei X, Song Z, Chen J. Xu S, et al. Among authors: zhang h. Front Oncol. 2021 Jul 8;11:667148. doi: 10.3389/fonc.2021.667148. eCollection 2021. Front Oncol. 2021. PMID: 34307137 Free PMC article.

5

Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications.

Wang H, Zhang H, Zhu Y, Wu Z, Cui C, Cai F. Wang H, et al. Among authors: zhang h. Front Oncol. 2021 Jul 26;11:654428. doi: 10.3389/fonc.2021.654428. eCollection 2021. Front Oncol. 2021. PMID: 34381705 Free PMC article. Review.

6

Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients.

Jin S, Zeng H, Liu Z, Jin K, Liu C, Yan S, Yu Y, You R, Zhang H, Chang Y, Xu L, Xu J, Wang Z, Zhu Y. Jin S, et al. Among authors: zhang h. Ann Surg Oncol. 2022 Apr;29(4):2495-2503. doi: 10.1245/s10434-021-11155-y. Epub 2022 Jan 9. Ann Surg Oncol. 2022. PMID: 35000080

7

Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma.

Zhu Y, Hong YP, Zhang HL, Shi GH, Xiao WJ, Wang ZH, Yao XD, Zhang SL, Dai B, Ye DW. Zhu Y, et al. Among authors: zhang hl, zhang sl. J Cancer Res Clin Oncol. 2012 Nov;138(11):1901-7. doi: 10.1007/s00432-012-1266-3. Epub 2012 Jun 29. J Cancer Res Clin Oncol. 2012. PMID: 22744643

8

The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer.

Yong L, Tang S, Yu H, Zhang H, Zhang Y, Wan Y, Cai F. Yong L, et al. Among authors: zhang h, zhang y. Front Oncol. 2022 Aug 8;12:964934. doi: 10.3389/fonc.2022.964934. eCollection 2022. Front Oncol. 2022. PMID: 36003773 Free PMC article. Review.

9

The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.

Hua S, Wang W, Yao Z, Gu J, Zhang H, Zhu J, Xie Z, Jiang H. Hua S, et al. Among authors: zhang h. J Cancer Res Clin Oncol. 2024 Jan 27;150(2):40. doi: 10.1007/s00432-023-05580-7. J Cancer Res Clin Oncol. 2024. PMID: 38279987 Free PMC article.

10

CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.

Tang S, Zhang Y, Lin X, Wang H, Yong L, Zhang H, Cai F. Tang S, et al. Among authors: zhang h, zhang y. Oncol Lett. 2022 Jun 28;24(2):285. doi: 10.3892/ol.2022.13405. eCollection 2022 Aug. Oncol Lett. 2022. PMID: 35814828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130,559 results

Search Page

Filters